Results 211 to 220 of about 2,955,039 (285)
Transcutaneous Electrical Acupoint Stimulation (TEAS) Facilitates Postoperative Recovery in Day Lung Cancer Surgery: A Randomized Controlled Trial. [PDF]
Wu S+7 more
europepmc +1 more source
Abstract Aims Atrial functional tricuspid regurgitation (AFTR) is increasingly recognized as a distinct cause of tricuspid regurgitation, yet data on outcomes and their determinants are limited. This study examines the prognostic role of right atrial (RA) remodelling in patients with severe AFTR.
Soongu Kwak+8 more
wiley +1 more source
Ropivacaine combined with esketamine in ultrasound-guided thoracic paravertebral nerve block in lung cancer patients undergoing thoracoscopic radical surgery. [PDF]
Wen J+5 more
europepmc +1 more source
The landscape of epilepsy surgery in older adults: Challenges and opportunities
Abstract The prevalence of epilepsy increases with age, and with the aging population, the number of drug‐resistant epilepsy (DRE) cases is expected to rise. However, epilepsy surgery remains underutilized and is typically offered to younger adults. Despite historical hesitancy due to concerns over risks and outcomes, evidence over the last two decades
Vineet Punia
wiley +1 more source
Comparing the Efficacy of Endoscopic Carpal Tunnel Repair Versus Open Surgery: A Systematic Review and Meta-analysis of Randomized Control Trials. [PDF]
Almojel YA+8 more
europepmc +1 more source
ABSTRACT Background In recent years, particle therapy has shown promise as a local treatment for salivary gland carcinoma (SGC); however, its efficacy and safety remain unclear. This study aimed to evaluate the clinical outcomes of intensity‐modulated proton therapy (IMPT) for SGC.
Gaku Takano+16 more
wiley +1 more source
Use of Digital and Telemedicine Tools for Postoperative Pain Management at Home: A Scoping Review of Health Professionals' Roles and Clinical Outcomes. [PDF]
Azzellino G+4 more
europepmc +1 more source
ABSTRACT Background The NTRK fusion gene is detected in most salivary gland secretory carcinomas. While tropomyosin receptor kinase (TRK) inhibitors are used for various solid tumors with the fusion gene, there are no reports regarding TRK inhibitor use for unresectable parotid gland carcinomas that subsequently shrink and become resectable.
Arisa Nagano+11 more
wiley +1 more source